All News #Library
Biotech
Gylden Priorities for Advancing Innovative for Infectious Diseases
24 Feb 2025 //
GLOBENEWSWIRE
Emergex Changes Name To “Gylden Pharma Limited” For Expansion
17 Oct 2024 //
GLOBENEWSWIRE
Emergex Vaccine Candidate Selected by NIH/NIAID for Trials
02 Oct 2024 //
GLOBENEWSWIRE
Emergex Gets Patent For Long-Term T Cell Immunity Influenza Vaccines
22 Aug 2024 //
GLOBENEWSWIRE
Emergex Announces MHRA Approval For Manufacturing And Import License
18 Jun 2024 //
GLOBENEWSWIRE
Emergex Signs Contract of £1.79M with UK Department of Health and Social Care
17 Nov 2023 //
GLOBENEWSWIRE
Emergex and Saudi Arabia`s VIC have Signed MoU
05 Oct 2023 //
GLOBENEWSWIRE

Market Place
Sourcing Support